Prazosin Looks Promising for Agitation in Dementia

Agitation can be a disruptive, chronic problem in Alzheimer’s. It increases caregiver burden as well as patient distress and is often the trigger to long-term care outside the home. ADCS is testing the generic drug prazosin as a treatment for agitation, as it promises to be well-tolerated in frail and elderly people with dementia.

Read more »